(DHR)

Reporting relationship: SVP-Chief Legal Officer
Issuer ticker: DHR
Reported as of: 04 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Aug 2026, 17:00:47 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ James F. O'Reilly, attorney-in-fact for Jonathan Leiken

Key filing fact

Jonathan Leiken filed Form 4 for DANAHER CORP /DE/ (DHR) on 06 Aug 2026.

Key facts

This page summarizes Jonathan Leiken's Form 4 filing for DANAHER CORP /DE/ (DHR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Aug 2026, 17:00.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001608984 Primary reporting owner

Leiken Jonathan

Relationship: SVP-Chief Legal Officer
Address: 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON
Signature: /s/ James F. O'Reilly, attorney-in-fact for Jonathan Leiken
Signature date: 06 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DHR transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
Shares: +92,138
Change %
Price: $0.000000^*
Shares after: 92,138
Date: 04 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 92,138
Exercise price: $194.78
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On the date indicated, Danaher Corporation granted the reporting person employee stock options in the indicated amount in connection with the Issuer's Long-Term Growth Program, as previously reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 3, 2026.

Footnote F2

Fifty percent of the options granted become exercisable on each of the fourth and fifth anniversaries of the grant date, which is August 4, 2026.